在肝胆道癌症中分子测试和向治疗:一篇评论
Diamantis I Tsilimigras1, Razelle Kurzrock2, Timothy M Pawlik1,3
1Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus.
JAMA surgery
|March 19, 2025
概括
分子测试和向疗法正在彻底改变肝胆癌治疗. 下一代测序的进步使个性化医疗成为可能,改善了侵袭性癌症的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肝胆道癌 (HCC和BTC) 的预后不佳.
- 下一代测序 (NGS) 揭示了分子复杂性.
- 在BTC中,有针对性的改变比HCC更常见.
研究的目的:
- 审查分子测试在肝胆癌症中的作用.
- 检查基因和免疫向疗法的影响.
- 讨论针对个性化瘤学的新型临床试验设计.
主要方法:
- 对肝胆道癌症的NGS近期进展的综述.
- 对已批准的向疗法和免疫疗法的分析.
- 对无瘤和N-of-1临床试验设计的检查.
主要成果:
- NGS识别了BTC的可操作变化,导致FDA批准的疗法.
- 免疫疗法越来越多地用于HCC和BTC.
- 瘤不可知疗法和N-of-1试验显示了个性化治疗的前景.
结论:
- 分子测试和向疗法正在改变肝胆癌的治疗.
- 瘤不可知和N-of-1试验代表了向个性化瘤学转变的范式.
- 需要进一步的研究来将这些方法整合到可操作的疾病管理中.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...